Related Experiment Video
Updated: Oct 3, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Avoidance of surgery for head and neck infantile myofibromatosis using imatinib monotherapy
Prasanth Pattisapu1,2, Tara L Wenger3, John P Dahl4,5
1Department of Otolaryngology-Head & Neck Surgery Nationwide Children's Hospital and The Ohio State University Columbus Ohio USA.
Abstract:
Describe a novel use for a kinase inhibitor, imatinib, in young children with a known activated somatic mutation in PDGFR-beta. Two patients with infantile myofibromatosis treated with imatinib. Case description of evaluation, diagnosis and treatment decisions for infantile myfibromatosis of the head and neck. Description of medical therapy for infantile myofibromatosis in these patients. For function threatening myofibromas of a known genotype, in infants, targeted medical therapy is a treatment option.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cystic Fibrosis: Management
Sinus disease and chronic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Treatment Resistant Cancers
Mitral Stenosis III: Medical Management
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

